14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $42.08 $57.25 Thursday, 2nd May 2024 LEGN stock ended at $45.93. This is 4.43% more than the trading day before Wednesday, 1st May 2024. During the day the stock fluctuated 5.32% from a day low at $43.65 to a day high of $45.97.
90 days $42.08 $70.13
52 weeks $42.08 $77.32

Historical Legend Biotech Corporation prices

Date Open High Low Close Volume
May 02, 2024 $44.50 $45.97 $43.65 $45.93 985 228
May 01, 2024 $43.69 $44.76 $42.08 $43.98 1 520 268
Apr 30, 2024 $44.99 $45.73 $43.64 $43.74 1 264 001
Apr 29, 2024 $45.64 $46.46 $45.06 $45.14 954 343
Apr 26, 2024 $44.30 $45.32 $44.28 $45.30 887 242
Apr 25, 2024 $44.94 $45.19 $44.06 $44.42 1 849 387
Apr 24, 2024 $48.18 $48.55 $45.12 $45.17 1 087 868
Apr 23, 2024 $47.54 $47.85 $45.70 $47.45 1 440 885
Apr 22, 2024 $46.37 $47.17 $45.52 $47.06 744 080
Apr 19, 2024 $47.12 $47.30 $45.68 $46.19 1 231 213
Apr 18, 2024 $48.50 $48.97 $47.09 $47.12 816 005
Apr 17, 2024 $51.39 $51.55 $48.03 $48.83 1 361 890
Apr 16, 2024 $50.00 $50.58 $48.98 $50.12 2 603 919
Apr 15, 2024 $52.82 $53.55 $51.47 $51.71 962 528
Apr 12, 2024 $54.68 $54.68 $52.92 $52.92 513 418
Apr 11, 2024 $55.50 $55.62 $54.15 $55.01 586 055
Apr 10, 2024 $55.00 $56.14 $54.86 $55.49 543 315
Apr 09, 2024 $54.24 $56.78 $54.12 $56.36 1 151 362
Apr 08, 2024 $55.00 $55.91 $54.20 $54.80 1 659 306
Apr 05, 2024 $55.07 $55.24 $53.89 $54.93 644 989
Apr 04, 2024 $56.66 $57.12 $54.83 $55.14 854 060
Apr 03, 2024 $57.25 $57.25 $55.21 $56.38 678 226
Apr 02, 2024 $57.01 $57.01 $55.91 $56.43 681 896
Apr 01, 2024 $57.37 $57.64 $56.00 $57.22 870 092
Mar 28, 2024 $56.59 $56.87 $55.00 $56.09 629 975
Click to get the best stock tips daily for free!

About Legend Biotech Corporation

Legend Biotech Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multiple myeloma (MM), as well as a comparison of the treatment with standard triplet therapy in revlimid-refr... LEGN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT